Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1995
05/18/1995CA2175249A1 Butyric ester cyto-differentiating agents
05/18/1995CA2172809A1 Pyrimidine-thioalkyl and alkylether compounds
05/18/1995CA2153498A1 Chroman derivative and medicinal use thereof
05/18/1995CA2135837A1 Pharmaceutical agents for treatment or prevention of sunburn
05/17/1995EP0653439A2 Stabilized oligonucleotids and the use thereof
05/17/1995EP0653438A2 Oligonucleotide compounds, their production and use
05/17/1995EP0653436A1 5-Methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4T)
05/17/1995EP0653434A1 Glucosamine derivative, process for preparing the same and synthetic intermediate thereof
05/17/1995EP0653427A1 Galanthamine derivatives, a process for their preparation and their use as medicaments
05/17/1995EP0653425A1 1-(2-Fluorocyclopropyl)-quinolone- and naphthyridone carboxylic acid derivatives, their preparation and their use as antibacterials
05/17/1995EP0653214A1 Topical antibacterial preparation
05/17/1995EP0653210A1 Intravenous applicable aqueous solution compressing sulfametrol and trimethoprim
05/17/1995EP0653209A1 Remedy for inflammatory intestinal diseases
05/17/1995EP0653208A2 Pharmaceutical agents for treatment or prevention of sunburn
05/17/1995EP0653207A1 Aids virus infection inhibitor composition
05/17/1995EP0653206A1 Anti-hiv agent
05/17/1995EP0653205A1 Non-chloroflurocarbon aerosol formulations
05/17/1995EP0653203A1 Novel zirconium salts and their synthesis
05/17/1995EP0652972A1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure
05/17/1995EP0652952A1 Peptides inhibiting ras protein activity, preparation and use thereof
05/17/1995EP0652948A1 Development of a vector to target gene expression to the epidermis of transgenic animals
05/17/1995EP0652890A1 Oligonucleotide alkylphosphonothioates
05/17/1995EP0652888A1 INHIBITION OF $i(CANDIDA)
05/17/1995EP0652887A1 New derivatives of neuraminic acid
05/17/1995EP0652886A1 Esterification process
05/17/1995EP0652879A1 1-azaadamantane derivatives as 5-ht agonists or antagonists
05/17/1995EP0652878A1 Pyridoindolobenzodiazepines and derivatives as antipsychotics
05/17/1995EP0652877A1 Methanesulphonate
05/17/1995EP0652875A1 (hetero)-aryl ketones derivatives with antibacterial properties
05/17/1995EP0652874A1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
05/17/1995EP0652873A1 Benzodiazepine derivatives
05/17/1995EP0652872A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds
05/17/1995EP0652871A1 Benzodiazepine derivatives
05/17/1995EP0652870A1 Process for preparing chiral (((2-bromoethyl)amino)methyl)-2-nitro-1H-imidazol-1- ethanol and related compounds
05/17/1995EP0652868A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF
05/17/1995EP0652867A1 Novel pyridyl- and pyrimidylpiperazine derivatives
05/17/1995EP0652866A1 Azacyclic compounds
05/17/1995EP0652864A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds
05/17/1995EP0652863A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
05/17/1995EP0652768A1 Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon-alpha and histamine, serotonin or substances with corresponding receptor activity
05/17/1995EP0652767A1 Treatment of human lactation failure
05/17/1995EP0652759A1 Ibuprofen-antacid combinations
05/17/1995EP0652757A1 Sugar-free dry mix cellulose ether compositions as bulk laxatives
05/17/1995EP0652756A1 Pharmaceutical compositions and use of dilinoleoylphosphatidylcholine (dlpc) for treatment and prevention of cirrhosis and fibrosis in the liver
05/17/1995EP0652754A1 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
05/17/1995EP0652753A1 Treatment of dentoalveolar infections with taurolidine and/or taurultam
05/17/1995EP0652752A1 Water-dispersible tablets
05/17/1995EP0652751A1 Injection and injection kit containing omeprazole and its analogs.
05/17/1995EP0652750A1 Use of alpha,omega-dicarboxylic acids as fibrinogen reducers
05/17/1995EP0652749A1 METHODS AND COMPOSITIONS FOR INHIBITING 5$g(a)-REDUCTASE ACTIVITY
05/17/1995EP0652748A1 A method of increasing creatine supply depot
05/17/1995EP0652747A1 Controlled release morphine preparation
05/17/1995EP0652743A1 Oral compositions.
05/17/1995EP0567582B1 Liposomal-polyene preliposomal powder and method for its preparation
05/17/1995EP0553191B1 Pyridine and pyridine n-oxide derivatives of diarylmethyl- piperidines or piperazines, compositions and use thereof
05/17/1995EP0510158B1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and metal salts
05/17/1995EP0506792B1 Insulin preparations containing nicotinic acid or nicotinamide
05/17/1995EP0497816B1 Treatment of hiv infections and compounds useful therein
05/17/1995EP0484446B1 Carnitine supplemented finishing pig diet
05/17/1995EP0365613B1 Combination of tobramycin and steroids for topical ophthalmic use
05/17/1995CN1102649A Piperidines and piperazines
05/17/1995CN1102648A Substituted mono- and bipyridylmethylpyridenes
05/17/1995CN1102645A Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives
05/17/1995CN1102643A Substituted derivatives of diaminophthalimide
05/17/1995CN1102640A Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
05/17/1995CN1102567A Group of drugs with antitussive and expectorant functions
05/17/1995CN1028436C Zhijiang vaccine and its prepn. method and produced medicine for prevention and cure of livestock and fowls' diseases therefrom
05/17/1995CN1028430C Process for preparing new derivatives of 1-dethia 2-thia cephalosporanic acids
05/17/1995CN1028429C Method for preparing of substd. Thieno (2,3-B)(1,5) benzodiazepine derivatives
05/17/1995CN1028427C Rhizoxin derivatives and their use as antitumor agents
05/17/1995CN1028408C New 1,4-diazepine derivatives having antiulcer activity
05/17/1995CA2135548A1 Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthyridonecarboxylic acid
05/16/1995US5416225 Total synthesis of taxol
05/16/1995US5416222 3-pyrrolidine methanamines wherein the alpha-carbon is substituted by 1 or 2 lower alkyl groups which are intermediates for pyridone-carboxylic acid derivatives
05/16/1995US5416221 Carbazolone derivatives
05/16/1995US5416209 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes
05/16/1995US5416203 Steroid modified oligonucleotides
05/16/1995US5416120 4-Ethyl-2-hydroxyimino-5-nitro-3-hexenamide
05/16/1995US5416119 Alkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertension
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995US5416116 Pediculicidal medicaments comprising derivatives of undecylenic/undecanoic acids
05/16/1995US5416114 Physiologically active and nutritional composition
05/16/1995US5416113 Bronchodilators
05/16/1995US5416112 Antiinflammatory agents
05/16/1995US5416111 Cyano-containing n-phenyl-amino-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416106 Ocular hypotensive agents
05/16/1995US5416105 Treating an arteriosclerosis with glimepiride
05/16/1995US5416104 Oxazolidinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416099 Fibrinogen receptor antagonists
05/16/1995US5416098 Antiallergens
05/16/1995US5416096 7-(1-pyrrolidinyl)-3-quinolone carboxylic acid derivatives as antibacterial agents and feed additives
05/16/1995US5416095 Tetrahydro-quinolinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416094 Antiarrhythmic and cardioprotective substituted -1(2H)isoquinolines, medicament containing them, and their use for combating heart failures
05/16/1995US5416092 3-azabicyclo[3.2.1]-oct-8-yl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416090 Ergoline analogues
05/16/1995US5416089 Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
05/16/1995US5416087 Bis-benzo, cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use
05/16/1995US5416085 3-oxa-8-azabicyclo[3.2.1]oct-8-yl terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416084 Benzo-fused thiomorpholinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/16/1995US5416083 Benzodiazepinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents